We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Genetic Basis for Growth Hormone Action Identified

By Biotechdaily staff writers
Posted on 30 Dec 2003
Researchers investigating the molecular basis for aging have found that the ability of growth hormone to increase lean body mass and bone density in the elderly and to stimulate regeneration of the liver is directly related to the activity of the Foxm1b gene.

The forkhead box (Fox) proteins, encoded by Foxm1b and related genes, are an extensive family of transcription factors that share homology in the winged helix/forkhead DNA- binding domain and play important roles in regulating cellular proliferation, differentiation, longevity, and cellular transformation.

Investigators at the University of Illinois at Chicago (USA) worked with populations of young (two-month-old) and aged (12-month-old) mice to study the effect of Foxm1b and growth hormone on liver regeneration. More...


They found that administration of growth hormone to aged mice whose livers had been partially removed significantly increased the activity of the Foxm1b gene. The livers of these animals regenerated at a pace similar to that of young mice. Cell proliferation peaked at just two days, and the liver was fully restored within a week. Liver regeneration in aged mice that did not receive hormone injections required a month or longer.

Growth hormone treatment of young mice that had been genetically engineered to lack the Foxm1b gene failed to restore regenerating liver cell DNA replication and mitosis caused by Foxm1b deficiency. These results, published in the December, 2003, issue of Hepatology, provided strong evidence that the presence of Foxm1b was essential for growth hormone to stimulate regenerating liver cell proliferation.

"Growth hormone levels decline as we grow older; as a result, the Foxm1b gene stops working and our bodies are less capable of repairing damage,” explained senior author Dr. Robert Costa, professor of biochemistry and molecular genetics at the University of Illinois at Chicago. "These results clearly demonstrate that Foxm1b is essential for growth hormone to spur liver regeneration.”




Related Links:
University of Illinois at Chicago

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.